Total Synthesis of the CP-Molecules (CP-263,114 and CP-225,917, Phomoidrides B and A)

Total Page:16

File Type:pdf, Size:1020Kb

Total Synthesis of the CP-Molecules (CP-263,114 and CP-225,917, Phomoidrides B and A) Published on Web 02/16/2002 Total Synthesis of the CP-Molecules (CP-263,114 and CP-225,917, Phomoidrides B and A). 3. Completion and Synthesis of Advanced Analogues K. C. Nicolaou,* Y.-L. Zhong, P. S. Baran, J. Jung, H.-S. Choi, and W. H. Yoon Contribution from the Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, and Department of Chemistry and Biochemistry, UniVersity of California, San Diego, 9500 Gilman DriVe, La Jolla, California 92093 Received August 20, 2001 Abstract: The completion of the total syntheses of the CP-molecules is reported. Several strategies and tactics, including the use of amide-based protecting groups for the homologated C-29 carboxylic acid and the use of an internal pyran protecting group scheme, are discussed. The endeavors leading to the design of new methods for the homologation of hindered aldehydes and to the isolation of a polycyclic byproduct (23), which inspired the development of a new series of reactions based on iodine(V) reagents, are described. In addition, the discovery and development of the LiOH-mediated conversion of CP-263,114 (1)toCP- 225,917 (2) is described, and a mechanistic rationale is presented. Finally, a synthetic route to complex analogues of the CP-molecules harboring a maleimide moiety in place of the maleic anhydride is presented. Introduction Scheme 1. Second-Generation Strategy for the Total Synthesis of 1 and 2 In the preceding paper in this issue,1 basic strategies for the installation of the maleic anhydride, γ-hydroxylactone, and remote stereocenter at C-7 (“upper” side chain) of the CP- molecules (1 and 2, Scheme 1) were devised and carried out. In addition, a first generation synthetic route to the natural products was tested employing these new methodologies. Central to our synthetic plan was the premise that the advanced key intermediate 5 (Scheme 1) would eventually lead to the target structures. Arrival at this “checkpoint” in the synthetic “laby- rinth” permitted a systematic investigation of the timing of the individual steps in the final stages. Specifically, the correct order for the installation of the γ-hydroxylactone and the one-carbon homologation of the “lower” side chain (C-28 f C-29) remained to be addressed. Whether to first target CP-263,114 (1)orCP- 225,917 (2) was also a lingering question in our minds. In this paper, second- and third-generation strategies toward the CP- molecules are delineated. Most importantly, the design and discovery of new cascade reactions and synthetic technologies en route to 1 and 2, and designed analogues thereof, are described. Results and Discussion 1. Second-Generation Retrosynthetic Analysis. During our first-generation1 approach to 1 and 2, we attempted to install Scheme 2. Thus, if we were to perform the one-carbon the C-29 carbon after the construction of the γ-hydroxylactone homologation of C-28 prior to the γ-hydroxylactone formation, and failed, due to the frailty of the precursors. The only dilemma the latter operation would require the presence of a free 1,4- associated with inverting the order of these events is shown in diol such as the one generated from 7 upon hydrolysis of the acetal protecting group. In the event, the primary alcohol of * To whom correspondence should be addressed at the Department of that diol, when generated by acid catalysis, spontaneously Chemistry, The Scripps Research Institute. (1) Nicolaou, K. C.; Baran, P. S.; Zhong, Y.-L.; Fong, K. C.; Choi, H.-S. J. cyclized onto the proximate ester to furnish lactone 8 (see Am. Chem. Soc. 2002, 124, 2190-2201. Scheme 2), a stop that proved to be a dead end. Due to the 2202 VOL. 124, NO. 10, 2002 9 J. AM. CHEM. SOC. 10.1021/ja0120126 CCC: $22.00 © 2002 American Chemical Society Total Synthesis of the CP-Molecules. 3 ARTICLES Scheme 2. Conformationally Locked γ-Lactone 8 Resulting from Scheme 3. Construction of Benzyl Amide 17a Cyclization of 7 in the Presence of Acida a Reagents and conditions: (a) CSA (0.2 equiv), MeOH, 25 °C,1h, 90%. conformational rigidity in this system, and the sensitivity of neighboring functionalities, we were unable to open lactone 8. Efforts to reduce the C-29 carbon to the alcohol stage were complicated by protecting group incompatibilities. To circum- vent this problem, the reigning theme of our second-generation strategy (Scheme 1), which provided a potential solution to this roadblock, involved the enlistment of an amide functionality to disguise and deactivate the electrophilic center at C-29. In doing so, we could avoid the problems associated with the late-stage homologation of the first-generation strategy,1 lockup structures, and, subsequently, only face what we perceived to be the comparably facile task of amide hydrolysis. As shown in the retrosynthetic blueprint in Scheme 1, an intermediate of type 3 was targeted as a potential precursor to 2. Intermediate 3 was envisioned to arise from homologated intermediate 4 by employing the DMP-mediated cascade for γ-hydroxylactol construction described in the preceding paper.1 Retrohomolo- gation and protecting group manipulations led to the previously synthesized advanced key intermediate 5. 2. Explorations To Implement the Second-Generation Strategy. The attempted execution of the newly designed second-generation strategy toward the CP-molecules began with the advanced key intermediate 5 as shown in Scheme 3. Thus, removal of the isopropylidene group from 5 using aqueous AcOH furnished the diol 9 in 85% yield. DDQ-mediated formation2 of the seven-membered benzylidene acetal 10 (57% yield) followed by stepwise oxidation of the remaining hydroxyl a Reagents and conditions: (a) 90% aqueous AcOH, 25 °C, 5 h, 85%; (b) DDQ (2.0 equiv), fluorobenzene, 25 °C, 2.5 h, 57%; (c) DMP (3.0 group with DMP (90% yield) and then NaClO2 led to carboxylic equiv), NaHCO3 (10 equiv), CH2Cl2,25°C, 1 h, 90%; (d) NaClO2 (3.0 acid 12 in 78% yield via the intermediate aldehyde 11. equiv), NaH2PO4 (1.5 equiv), 2-methyl-2-butene (50 equiv), t-BuOH/H2O ° Optimization studies of the DDQ-mediated cyclization (see (2:1), 25 C, 20 min, 78%; (e) MsCl (5.0 equiv), Et3N (10 equiv), THF, ° f ° Table 1) led to the identification of fluorobenzene as a superior 0 C, 5 min; (f) CH2N2 (excess), Et2O/THF, 0 25 C, 1 h; (g) Ag2O (5.0 equiv), DMF/H2O (2:1), 120 °C, 1 min, 43% overall from 12; (h) PhCH2NH2 solvent for this transformation. (1.5 equiv), EDC (3.0 equiv), 4-DMAP (1.0 equiv), CH2Cl2,25°C,1h, To execute the planned Arndt-Eistert homologation protocol3 85%; (i) 80% aqueous AcOH, 25 °C, 1.5 h, 77%. TFA ) trifluoroacetic on carboxylic acid 12, we required a mild method for the acid;4-DMAP)4-(N,N-dimethylamino)pyridine;EDC)1-(3-(dimethylamino)- ) activation of hindered carboxylic acids since acid chloride propyl)-3-ethylcarbodiimide hydrochloride; PMP p-methoxyphenyl. formation with this system and others related to it was extremely to the highly hindered nature of the CP-skeleton. Specifically, inefficient or did not work at all. As we had done with the maleic we took advantage of the reactive and compact nature of the anhydride construction, we designed a method which responded acyl mesylate species to activate these sterically blocked systems (2) Oikawa, Y.; Yoshioka, T.; Yonemitsu, O. Tetrahedron Lett. 1982, 23, 889. for attack by diazomethane, a small reagent itself. The developed (3) (a) Arndt, F.; Eistert, B.; Partale, W. Ber. Dtsch. Chem. Ges. 1927, 60, method4 is extremely mild, requiring only low temperatures 1364. (b) Arndt, F.; Amende, J. Ber. Dtsch. Chem. Ges. 1928, 61, 1122. (c) Arndt, F.; Eistert, B. Ber. Dtsch. Chem. Ges. 1935, 68B, 200. See also: Smith, A. B., III; Toder, B. H.; Branca, S. J. J. Am. Chem. Soc. 1984, 106, (4) Nicolaou, K. C.; Baran, P. S.; Zhong, Y.-L.; Choi, H.-S.; Fong, K. C.; He, 3995. Y.; Yoon, W. H. Org. Lett. 1999, 1, 883. J. AM. CHEM. SOC. 9 VOL. 124, NO. 10, 2002 2203 ARTICLES Nicolaou et al. Table 1. Optimization of the DDQ-Mediated Benzylidene Scheme 4. Attempted Hydrolysis of Benzyl Amide 20a Formation a Reagents and conditions: (a) DMP (5.0 equiv), benzene, 80 °C, 8 min, 35%; (b) TEMPO (10 equiv), PhI(OAc)2 (10 equiv), CH3CN, 25 °C,2h, 70%. Table 2. Optimization of the Wolff Rearrangement Leading to Carboxylic Acid 15 Scheme 5. Use of the Martin Sulfurane for the Conversion of Anilides to Esters and Carboxylic Acidsa a See ref 7. leading to diol 17. The latter compound was found to be resistant to cyclization as predicted. With diol 17 in hand, the stage was now set for the application of the DMP cascade oxidation sequence to install the γ-hydroxy- lactone functionality (Scheme 4). Thus, treatment of 17 with DMP in refluxing benzene led to the γ-hydroxylactol 19 in 35% yield. TEMPO-mediated conversion of 19 to the lactone 20 proceeded smoothly in 70% yield. However, and despite for rapid activation. Thus, carboxylic acid 12 was smoothly encouraging model studies,6 amide 20 resisted hydrolysis under transformed into diazo ketone 14 via the acyl mesylate 13 upon conditions required for the survival of the parent structures. This ° treatment with MsCl/Et3Nat0 C followed by addition of excess time, we had successfully constructed the entire CP skeleton CH2N2 as a dried ethereal solution. The generality of this with correct oxidation states at all centers only to be frustrated protocol and relevant mechanistic studies have been reported by one protecting group which refused to dismantle as expected.
Recommended publications
  • Organic Synthesis: Handout 1
    Prof Tim Donohoe: Strategies and Taccs in Organic Synthesis: Handout 1 Organic Synthesis III 8 x 1hr Lectures: Michaelmas Term Weeks 5-8 2016 Mon at 10am; Wed at 9am Dyson Perrins lecture theatre Copies of this handout will be available at hEp://donohoe.chem.ox.ac.uk/page16/index.html 1/33 Prof Tim Donohoe: Strategies and Taccs in Organic Synthesis: Handout 1 Organic Synthesis III Synopsis 1) Introduc5on to synthesis: (i) Why do we want to synthesise molecules- what sort of molecules do we need to make? (ii) What aspects of selecvity do we need to accomplish a good synthesis (chemo-, regio- and stereoselecvity)? (iii) Protecng group chemistry is central to any syntheAc effort (examples and principles) (iv) What is the perfect synthesis (performed in industry versus academia)? 2) The chiral pool: where does absolute stereochemistry come from? 3) Retrosynthesis- learning to think backwards (revision from first and second year). Importance of making C-C bonds and controlling oxidaAon state. Umpolung 4) Some problems to think about 5) Examples of retrosynthesis/synthesis in ac5on. 6) Ten handy hints for retrosynthesis 7) Soluons to the problems Recommended books: General: Organic Chemistry (Warren et al) Organic Synthesis: The DisconnecRon Approach (S. Warren) Classics in Total Synthesis Volumes I and II (K. C. Nicolaou) The Logic of Chemical Synthesis (E. J. Corey) 2/33 View Article Online / Journal Homepage / Table of Contents for this issue 619461 Strychniqae and BYucine. Pavt XLII. 903 Prof Tim Donohoe: Strategies and Taccs in Organic Synthesis: Handout 1 (i) Why do we want to synthesise complex molecules? Isolated from the Pacific Yew in 1962 Prescribed for prostate, breast and ovarian cancer Unique mode of acRon 1x 100 year old tree = 300 mg Taxol Isolated in 1818- poisonous Stuctural elucidaon took R.
    [Show full text]
  • Enantioselective Total Synthesis of (-)-Deoxoapodine
    Enantioselective total synthesis of (-)-deoxoapodine The MIT Faculty has made this article openly available. Please share how this access benefits you. Your story matters. Citation Kang, Taek, et al., "Enantioselective total synthesis of (-)- deoxoapodine." Angewandte Chemie International Edition 56, 44 (Sept. 2017): p. 13857-60 doi 10.1002/anie.201708088 ©2017 Author(s) As Published 10.1002/anie.201708088 Publisher Wiley Version Author's final manuscript Citable link https://hdl.handle.net/1721.1/125957 Terms of Use Creative Commons Attribution-Noncommercial-Share Alike Detailed Terms http://creativecommons.org/licenses/by-nc-sa/4.0/ HHS Public Access Author manuscript Author ManuscriptAuthor Manuscript Author Angew Manuscript Author Chem Int Ed Engl Manuscript Author . Author manuscript; available in PMC 2018 October 23. Published in final edited form as: Angew Chem Int Ed Engl. 2017 October 23; 56(44): 13857–13860. doi:10.1002/anie.201708088. Enantioselective Total Synthesis of (−)-Deoxoapodine Dr. Taek Kang§,a, Dr. Kolby L. White§,a, Tyler J. Mannb, Prof. Dr. Amir H. Hoveydab, and Prof. Dr. Mohammad Movassaghia aDepartment of Chemistry, Massachusetts Institute of Technology Cambridge, MA 02139 (USA) bDepartment of Chemistry, Merkert Chemistry Center, Boston College, Chestnut Hill, MA 02467 (USA) Abstract The first enantioselective total synthesis of (−)-deoxoapodine is described. Our synthesis of this hexacyclic aspidosperma alkaloid includes an efficient molybdenum-catalyzed enantioselective ring-closing metathesis reaction for desymmetrization of an advanced intermediate that introduces the C5-quaternary stereocenter. After C21-oxygenation, the pentacyclic core was accessed via an electrophilic C19-amide activation and transannular spirocyclization. A biogenetically inspired dehydrative C6-etherification reaction proved highly effective to secure the F-ring and the fourth contiguous stereocenter of (−)-deoxoapodine with complete stereochemical control.
    [Show full text]
  • Albert A. Bowers, Ph.D
    CURRICULUM VITAE Albert A. Bowers, Ph.D. A) PERSONAL INFORMATION Division of Chemical Biology and Medicinal Chemistry Phone: 919-962-4336 Eshelman School of Pharmacy Email : [email protected] 3107 Marsico Hall WeB: http://bowerslab.web.unc.edu 125 Mason Farm Rd. Twitter: @BowersRangers Chapel Hill, NC 27599 B) EDUCATION 2007 Doctor of Philosophy (Ph.D.) in Chemistry The University of Illinois at Chicago, Chicago, IL. 2001 Bachelor of Arts (B.A.) in Art History University of Chicago, Chicago, IL. C) PROFESSIONAL EXPERIENCE 06/2018-present Associate Professor, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 08/2012-05/2018 Assistant Professor, Division of Chemical Biology and Medicinal Chemistry, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 08/2011-07/2012 Assistant Professor, Department of Medicinal Chemistry and Molecular Pharmacology, Purdue University, West Lafayette, IN 2011 Visiting scholar, National Institutes of Health, Bethesda, MD Host: Dr. David L. Levens 2005 Visiting scholar, Kyoto University, Kyoto, Japan Host: Prof. Jun-Ichi Yoshida 01/2009-07/2011 Post-doctoral Fellow, Dept. of Biological Chemistry & Molecular Pharmacology, Harvard Medical School, Boston, MA. Advisor: Prof. Christopher T. Walsh 08/2007-12/2008 Post-doctoral Fellow, Dept. of Chemistry, Colorado State University, Fort Collins, CO. Advisor: Prof. RoBert M. Williams D) HONORS AND AWARDS 2018 U. Tokyo/Japan Society for the Promotion of Science Tateshina Young Investigator Award 2016 Boulder Peptide Society Young Investigator Award 2014 Beckman Young Investigator Award 2013 American Association of Colleges of Pharmacy New Investigator Award 2013 Junior Faculty Development Award (UNC) 2008 NIH (NCI) Ruth L Kirschstein Postdoctoral Fellowship (F32) 2006 RoBert M.
    [Show full text]
  • The Total Synthesis of Securinine and Other Methodology Studies
    University of Windsor Scholarship at UWindsor Electronic Theses and Dissertations Theses, Dissertations, and Major Papers 2010 The total synthesis of securinine and other methodology studies Bhartesh Dhudshia University of Windsor Follow this and additional works at: https://scholar.uwindsor.ca/etd Recommended Citation Dhudshia, Bhartesh, "The total synthesis of securinine and other methodology studies" (2010). Electronic Theses and Dissertations. 8275. https://scholar.uwindsor.ca/etd/8275 This online database contains the full-text of PhD dissertations and Masters’ theses of University of Windsor students from 1954 forward. These documents are made available for personal study and research purposes only, in accordance with the Canadian Copyright Act and the Creative Commons license—CC BY-NC-ND (Attribution, Non-Commercial, No Derivative Works). Under this license, works must always be attributed to the copyright holder (original author), cannot be used for any commercial purposes, and may not be altered. Any other use would require the permission of the copyright holder. Students may inquire about withdrawing their dissertation and/or thesis from this database. For additional inquiries, please contact the repository administrator via email ([email protected]) or by telephone at 519-253-3000ext. 3208. The Total Synthesis of Securinine and Other Methodology Studies by Bhartesh Dhudshia A Dissertation Submitted to the Faculty of Graduate Studies through the Department of Chemistry and Biochemistry in Partial Fulfillment of the Requirements
    [Show full text]
  • Scripps Florida Funding Corporation Annual Report
    SCRIPPS FLORIDA FUNDING CORPORATION ANNUAL REPORT FOR THE YEAR ENDED SEPTEMBER 30, 2020 Scripps Florida Funding Corporation Annual Report For Year Ended September 30, 2020 INTRODUCTION Florida Statute 288.955 (the “Enabling Statute”) created Scripps Florida Funding Corporation (“SFFC”) to facilitate the establishment and operation of a biomedical research institution for the purposes of enhancing education and research and promoting economic development and diversity. In addition, the Enabling Statute charged SFFC with the obligation to assure the compliance by The Scripps Research Institute (“TSRI”) with the Enabling Statute and the agreement between SFFC and TSRI (the “Operating and Funding Agreement”). The Enabling Statute provides that SFFC shall prepare or obtain certain reports, audits, and evaluations of TSRI’s compliance with the performance expectations and disbursement conditions contained in the Enabling Statute. As such, SFFC is submitting this Annual Report to the Governor, the President of the Senate, and the Speaker of the House, as required by the Enabling Statute to be submitted by December 1 of each year. This SFFC Annual Report addresses the activities and outcomes of SFFC and Scripps Florida (“SF”) for the fiscal year ended September 30, 2020 (“Fiscal 2020”). The Scripps Florida Annual Report addressed the activities and outcomes of Scripps Florida for the year ended June 30, 2020, and the information in the Scripps Florida Annual Report was informally updated for this SFFC Annual Report. The SFFC Annual Report is presented in two parts: first, a summary that highlights the substantial events that have occurred during the year ended September 30, 2020; and second, an itemized report that corresponds with the applicable sections of the Enabling Statute.
    [Show full text]
  • Recent Advances in Total Synthesis Via Metathesis Reactions
    SYNTHESIS0039-78811437-210X © Georg Thieme Verlag Stuttgart · New York 2018, 50, 3749–3786 review 3749 en Syn thesis I. Cheng-Sánchez, F. Sarabia Review Recent Advances in Total Synthesis via Metathesis Reactions Iván Cheng-Sánchez Francisco Sarabia* Department of Organic Chemistry, Faculty of Sciences, University of Málaga, Campus de Teatinos s/n. 29071- Málaga, Spain [email protected] Received: 16.04.2018 ly explained by the emergence, design, and development of Accepted after revision: 30.05.2018 powerful catalysts that are capable of promoting striking Published online: 18.07.2018 DOI: 10.1055/s-0037-1610206; Art ID: ss-2018-z0262-r transformations in highly efficient and selective fashions. In fact, the ability of many of them to forge C–C bonds be- Abstract The metathesis reactions, in their various versions, have be- tween or within highly functionalized and sensitive com- come a powerful and extremely valuable tool for the formation of car- pounds has allowed for the preparation of complex frame- bon–carbon bonds in organic synthesis. The plethora of available cata- lysts to perform these reactions, combined with the various works, whose access were previously hampered by the lim- transformations that can be accomplished, have positioned the me- itations of conventional synthetic methods. Among the tathesis processes as one of the most important reactions of this centu- myriad of recent catalysts, those developed and designed to ry. In this review, we highlight the most relevant synthetic contributions promote metathesis reactions have had a profound impact published between 2012 and early 2018 in the field of total synthesis, reflecting the state of the art of this chemistry and demonstrating the and created a real revolution in the field of total synthesis, significant synthetic potential of these methodologies.
    [Show full text]
  • Total Synthesis of ( )-Hennoxazole a Vol
    ORGANIC LETTERS − 2007 Total Synthesis of ( )-Hennoxazole A Vol. 9, No. 6 1153-1155 Thomas E. Smith,* Wen-Hsin Kuo, Victoria D. Bock, Jennifer L. Roizen, Emily P. Balskus, and Ashleigh B. Theberge Department of Chemistry, Williams College, Williamstown, Massachusetts 01267 [email protected] Received January 31, 2007 ABSTRACT An enantioselective, convergent, total synthesis of the antiviral marine natural product (−)-hennoxazole A has been completed in 17 steps, longest linear sequence, from serine methyl ester and in 9 steps from an achiral bisoxazole intermediate. Elaboration of a thiazolidinethione allowed for rapid assembly of the pyran-based ring system. Key late-stage coupling was effected by deprotonation of the bisoxazole methyl group, followed by alkylation with an allylic bromide side chain segment. Marine natural products have become increasingly important Williams,5 and Shioiri6 laboratories.7 In this communication, as lead compounds for the development of new drugs as a we report the shortest asymmetric total synthesis of hen- consequence of their intriguing structural diversity and noxazole A to date. biological activity.1 Hennoxazole A (1), first isolated by The development of relatively mild conditions for the Scheuer from the marine sponge Polyfibrospongia, displays preparation of oxazoles has made the late-stage assembly of antiviral activity against herpes simplex type 1, as well as these ring systems a common, albeit not always efficient, peripheral analgesic behavior.2 The two contiguous 2,4- strategy in the synthesis
    [Show full text]
  • Kalypsys to Provide the Florida Scripps Research Institute with Next- Generation Lead Discovery Technology
    KALYPSYS TO PROVIDE THE FLORIDA SCRIPPS RESEARCH INSTITUTE WITH NEXT- GENERATION LEAD DISCOVERY TECHNOLOGY 6/15/2005 San Diego, June 16, 2005 — Kalypsys, Inc., a privately owned drug discovery and development company and The Scripps Research Institute (TSRI) entered into an agreement in which Scripps will access Kalypsys' proprietary ultra-high throughput screening technologies as a key enablement for the newly created TSRI site in Florida. "We are pleased to be selected for this Florida initiative," stated John P. McKearn, president and CEO of Kalypsys. "Developing a state-of-the-art research center will have a significant impact on Florida's economic development in the area of biotechnology and biomedical research and we are honored our technology has been selected to assist in this endeavor." The Kalypsys technology platform is designed and manufactured to meet the specific needs of each partner. The platform is comprised of a suite of lead discovery solutions, including a highly automated, robotic, ultra-high throughput screening technology capable of screening a variety of biochemical and biologically relevant cellular assays in 1536-well formats. The power and robustness of the Kalypsys technologies make it ideally suited to probe a large number of diverse targets rapidly. With the Kalypsys system, Scripps Florida is developing leading-edge technologies to enable scientists to examine the basic biology of human health and find better treatments for a variety of devastating human diseases. A team of accomplished scientists is implementing research programs addressing diseases such as AIDS, cancer, diabetes, obesity, prion diseases, Parkinson's disease and schizophrenia among others. The research programs focus on genetic disease informatics, cancer biology, infectology, genetics, proteomics, drug metabolism and pharmacokinetics.
    [Show full text]
  • Spontaneous Generation & Origin of Life Concepts from Antiquity to The
    SIMB News News magazine of the Society for Industrial Microbiology and Biotechnology April/May/June 2019 V.69 N.2 • www.simbhq.org Spontaneous Generation & Origin of Life Concepts from Antiquity to the Present :ŽƵƌŶĂůŽĨ/ŶĚƵƐƚƌŝĂůDŝĐƌŽďŝŽůŽŐLJΘŝŽƚĞĐŚŶŽůŽŐLJ Impact Factor 3.103 The Journal of Industrial Microbiology and Biotechnology is an international journal which publishes papers in metabolic engineering & synthetic biology; biocatalysis; fermentation & cell culture; natural products discovery & biosynthesis; bioenergy/biofuels/biochemicals; environmental microbiology; biotechnology methods; applied genomics & systems biotechnology; and food biotechnology & probiotics Editor-in-Chief Ramon Gonzalez, University of South Florida, Tampa FL, USA Editors Special Issue ^LJŶƚŚĞƚŝĐŝŽůŽŐLJ; July 2018 S. Bagley, Michigan Tech, Houghton, MI, USA R. H. Baltz, CognoGen Biotech. Consult., Sarasota, FL, USA Impact Factor 3.500 T. W. Jeffries, University of Wisconsin, Madison, WI, USA 3.000 T. D. Leathers, USDA ARS, Peoria, IL, USA 2.500 M. J. López López, University of Almeria, Almeria, Spain C. D. Maranas, Pennsylvania State Univ., Univ. Park, PA, USA 2.000 2.505 2.439 2.745 2.810 3.103 S. Park, UNIST, Ulsan, Korea 1.500 J. L. Revuelta, University of Salamanca, Salamanca, Spain 1.000 B. Shen, Scripps Research Institute, Jupiter, FL, USA 500 D. K. Solaiman, USDA ARS, Wyndmoor, PA, USA Y. Tang, University of California, Los Angeles, CA, USA E. J. Vandamme, Ghent University, Ghent, Belgium H. Zhao, University of Illinois, Urbana, IL, USA 10 Most Cited Articles Published in 2016 (Data from Web of Science: October 15, 2018) Senior Author(s) Title Citations L. Katz, R. Baltz Natural product discovery: past, present, and future 103 Genetic manipulation of secondary metabolite biosynthesis for improved production in Streptomyces and R.
    [Show full text]
  • Sonogashira Coupling in Natural Product Synthesis
    Organic Chemistry Frontiers Sonogashira Coupling in Natural Product Synthesis Journal: Organic Chemistry Frontiers Manuscript ID: QO-REV-12-2013-000086.R1 Article Type: Review Article Date Submitted by the Author: 09-Feb-2014 Complete List of Authors: Wang, Dan; East China Normal University, Chemistry Gao, Shuanhu; East China Normal University, Chemistry CREATED USING THE RSC REPORT TEMPLATE (VER. 3.1) - SEE WWW.RSC.ORG/ELECTRONICFILES FOR DETAILS Page 1 of 19 Organic Chemistry Frontiers REVIEW www.rsc.org/xxxxxx | XXXXXXXX 1 Sonogashira Coupling in Natural Product 2 3 Synthesis 4 5 Dan Wang and Shuanhu Gao* 6 DOI: 10.1039/b000000x 7 8 5 Abstract: This review will focus on selected applications of Sonogashira 9 coupling and subsequent transformations as key steps in the total synthesis 10 of natural products. A brief introduction of the history and development of 11 Sonogashira coupling will be presented. The organization of the synthetic 12 applications is based on the structure of target molecules and the 13 10 transformations followed by the Sonogashira coupling, which includes (1) 14 preparation of natural products containing conjugated enynes or enediynes; 15 (2) Sonogashira coupling followed by stereoselective reduction and (3) 16 Sonogashira coupling followed by regioselective annulations. 17 18 19 1 Introduction 20 15 Significant advances have been made over the past four decades in palladium (Pd)- 21 catalyzed cross-coupling reactions to form carbon-carbon (C-C) bonds.1 As a result, 22 Pd-catalyzed inter- and intramolecular reactions and cyclizations are widely used to 23 synthesize natural products, therapeutic agents and organic materials.2 These 24 reactions dramatically improve the efficiency of organic syntheses, such as those 2 25 20 involving the formation of sp-sp bonds.
    [Show full text]
  • UC Merced Final Handout
    5/5/15 Overview Overview Creative Strategies: § Recruiting strategies and planning Graduate Outreach and § Identifying recruitment needs § Grant writing Diversity Recruiting § Noteworthy Department Information § Fellowships § Promotional Materials § Admitted Student Visitations § Attending graduate and professional school fairs Thomas Cahoon § HBCU Pilot Program § Campus Collaborations – hosting visitors § Future steps Recruiting strategies Recruitment Planning Recruitment Planning § Determine the target population § What type of diversity is missing? § Set a budget for the year § Determine activities outside dept as well as § How do you increase applications from § Create a Recruitment plan inside department underrepresented groups? § Get approval from supervisors and faculty § Promotional Materials - giveaways § Form a departmental diversity committee – § How can you save money for the § Engaging current students get faculty support department? § Engaging Faculty § How can your department benefit from diversity recruiting? Noteworthy Department Uniqueness of Program Graduate Programs Information Chemistry and Biochemistry § What is special about your program? • Analytical • Structural and § Is it faculty? • Biophysics Computational Biology § Is it research? • Inorganic • Systems Biology • Organic • Metabolism, Aging and § Is it the fact that you offer full funding? • Materials and Nanoscience Development • Physical • Bioenergy and the § Is it rankings? • Theory/Computation Environment 1 5/5/15 NOBEL LAUREATES ! THE NOBEL PRIZE IS WIDELY REGARDED AS THE MOST PRESTIGIOUS AWARD AVAILABLE IN ! THE FIELDS OF CHEMISTRY, ECONOMICS, LITERATURE, MEDICINE, PEACE, AND PHYSICS. U.S. News and World Report rankings: UCLA CHEMISTRY & BIOCHEMISTRY HAS THE DISTINCTION OF HAVING THE MOST ! NOBEL LAUREATES (3 FACULTY + 3 ALUMNI, 6 TOTAL NOBEL LAUREATES) ! 60 professors pursuing research in all Chemistry (overall): 15th OF ALL OF THE UCLA DEPARTMENTS. fields of Chemistry and Biochemistry Organic Chemistry: 16th Dr.
    [Show full text]
  • Research Organizations and Major Discoveries in Twentieth-Century Science: a Case Study of Excellence in Biomedical Research
    A Service of Leibniz-Informationszentrum econstor Wirtschaft Leibniz Information Centre Make Your Publications Visible. zbw for Economics Hollingsworth, Joseph Rogers Working Paper Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research WZB Discussion Paper, No. P 02-003 Provided in Cooperation with: WZB Berlin Social Science Center Suggested Citation: Hollingsworth, Joseph Rogers (2002) : Research organizations and major discoveries in twentieth-century science: A case study of excellence in biomedical research, WZB Discussion Paper, No. P 02-003, Wissenschaftszentrum Berlin für Sozialforschung (WZB), Berlin This Version is available at: http://hdl.handle.net/10419/50229 Standard-Nutzungsbedingungen: Terms of use: Die Dokumente auf EconStor dürfen zu eigenen wissenschaftlichen Documents in EconStor may be saved and copied for your Zwecken und zum Privatgebrauch gespeichert und kopiert werden. personal and scholarly purposes. Sie dürfen die Dokumente nicht für öffentliche oder kommerzielle You are not to copy documents for public or commercial Zwecke vervielfältigen, öffentlich ausstellen, öffentlich zugänglich purposes, to exhibit the documents publicly, to make them machen, vertreiben oder anderweitig nutzen. publicly available on the internet, or to distribute or otherwise use the documents in public. Sofern die Verfasser die Dokumente unter Open-Content-Lizenzen (insbesondere CC-Lizenzen) zur Verfügung gestellt haben sollten, If the documents have been made available under an Open gelten abweichend von diesen Nutzungsbedingungen die in der dort Content Licence (especially Creative Commons Licences), you genannten Lizenz gewährten Nutzungsrechte. may exercise further usage rights as specified in the indicated licence. www.econstor.eu P 02 – 003 RESEARCH ORGANIZATIONS AND MAJOR DISCOVERIES IN TWENTIETH-CENTURY SCIENCE: A CASE STUDY OF EXCELLENCE IN BIOMEDICAL RESEARCH J.
    [Show full text]